"As biopharmaceutical processes have reached commercial scale and are key to providing lifesaving and life-changing therapies, the challenges of business continuity planning and supply-chain risk mitigation are increasingly important. Without proper planning, businesses risk shortages of lifesaving medicines, increased costs and angry shareholders. This panel will uncover and share best practices from across the industry in order to foster better risk management of the global supply chain for bioproduction."

Objective1:"Review the challenges the biopharmaceutical industry faces in supply-chain risk mitigation."

Objective2:Address how different companies define business continuity planning and approach supply-chain risk mitigation.

Objective3:Define important considerations in business continuity planning and the different strategies employed.